| Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer (NCT04191460) | Erasmus Medical Center | 2022-07-12 |
| Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT04831450) | University of Miami | 2022-07-01 |
| Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer (NCT03459729) | Medical College of Wisconsin | 2021-08-24 |
| CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer (NCT03721757) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2019-05-10 |
| Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (NCT03575598) | University Health Network, Toronto | 2018-08-30 |
| Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03370276) | H. Lee Moffitt Cancer Center and Research Institute | 2017-12-20 |
| Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity (NCT02873819) | Gliknik Inc. | 2017-03-30 |
| Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients (NCT04387682) | National Taiwan University Hospital | 2017-03-22 |
| IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity (NCT02609386) | Brooklyn ImmunoTherapeutics, LLC | 2016-01-11 |
| Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity (NCT02331875) | Innate Pharma | 2014-12-01 |
| A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck (NCT01921426) | Galera Therapeutics, Inc. | 2013-08-01 |
| Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity (NCT01636544) | Institut Pasteur | 2012-06-15 |
| Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (NCT01265849) | CEL-SCI Corporation | 2010-12-01 |
| A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis (NCT01077869) | University Hospital, Ghent | 2010-01-01 |
| TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer (NCT01108042) | Orlando Guntinas-Lichius, Prof. Dr. med. | 2009-11-01 |
| Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium (NCT01321892) | Icahn School of Medicine at Mount Sinai | 2009-06-01 |